Clinical Decision Support Aiming to Accelerate Triage and Time to Dextrose-Containing IV Fluids in the ED for

Swaminathan Kandaswamy1, Shabnam Jain1,2, Dwight Diaz Chambers3

  • 1Department of Pediatrics, Emory University, Atlanta, Georgia, United States.

Applied Clinical Informatics
|September 11, 2025
PubMed

Insights

A new clinical decision support tool for children with metabolic diseases improved triage accuracy and reduced time to dextrose fluids. While not impacting ICU admissions, it highlights the value of user-centered design in pediatric care.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Decision Support Systems
  • Metabolic Disorders

Background:

  • Children with metabolic diseases are at high risk of rapid decompensation.
  • Effective clinical decision support (CDS) is crucial for timely intervention.
  • Human-centered design principles are vital for successful CDS implementation.

Purpose of the Study:

  • To describe the human-centered design of a CDS for pediatric metabolic diseases.
  • To assess the CDS's impact on care processes and patient outcomes.
  • To share implementation insights for future CDS development.

Main Methods:

  • Collaborative design of CDS with pediatric genetics experts.
  • Formative usability testing with emergency department (ED) nurses and providers.
  • Comparison of pre- and post-intervention data on triage, alert acceptance, order set usage, and clinical outcomes.

Main Results:

  • Provider alert acceptance rate was 39%.
  • Nurse triage acuity (Emergency Severity Index <3) increased from 84% to 98%.
  • Time to dextrose fluids administration from rooming decreased significantly (101 to 82 minutes).

Conclusions:

  • User-centered CDS design improved triage appropriateness and reduced time to critical fluids for pediatric metabolic emergencies.
  • The CDS did not significantly alter ICU admission rates or length of stay.
  • Usability testing and clinician-centered design are key for effective CDS integration in pediatric care.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
679
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258